Sinoway Industrial Co., Ltd.

Pitavastatin Kalsiyum 147526-32-7 Pitavastatin Kalsiyum 147526-32-7

Pitavastatin Kalsiyum 147526-32-7
İlgili Ürünler
  • L-Glutatyon Azaltılmış (GSH) 70-18-8

    L-Glutatyon Azaltılmış L-Glutatyon Azaltıcı Temel bilgiler: Ürün adı: L-Glutatyon Azaltılmış Moleküler Formül: C20H32N6O12S2 Moleküler Ağırlık: 612.63CAS No: 70-18-8ENIECE No: 200-725-4Appearanc ...

  • Bakır Peptid (GHK) 2-CU 49557-75-7

    Bakır peptit GHK-CuBazic bakır peptid GHK-Cu: Ürün Adı (GHK) 2-Cu (Bakır Peptid) EşanlamlıGHK-Cu (Bakır peptid) CAS # 49557-75-7Moleküler FormülC28H46N12O8Cu Moleküler Ağırlık742.2 ...

  • Soyada İzoflavonlar 574-12-9

    Soya Ekstresi1.Basit Ekstresi hakkında temel bilgiler: Ürün adı: Soya Ekstresi Kaynak: glisin maxUsed kısım: tohum / fasulye posası: toplam soya izoflavonu% 40, HPLCNameSoybean Ekstresi TozuTyp ...

Pitavastatin Kalsiyum 147526-32-7 temel bilgiler

Name

Pitavastatincalcium

CAS:

147526-32-7

Molecular Formula

C50H46CaF2N2O8

Molecular Weight

880.98

Quality Standard

In-house Standard, Assay: >99.0%

Package Size

For small quantity: Double plastic bag inside, Aluminum foil bag outside

For commercial quantity: 25kg fiber drum & Aluminum tin

Brief Introduction

Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication 
class of statins, marketed in the United States under the trade name Livalo. Like other statins, it
is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.

It has been available in Japan since 2003, and is being marketed in South Korea and in India.
[2] It is expected that pitavastatin will be approved outside Southeast Asia as well.
[3] In the US, it received FDA approval in 2009. Kowa Pharmaceuticals is the owner of the American patent to pitavastatin.


Pitavastatin Kalsiyum 147526-32-7 kullanımı

  • Pitavastatin kalsiyum hiperkolesterolemi (yüksek kolesterol) ve kardiyovasküler hastalıkların önlenmesi için endikedir.

Pitavastatin Kalsiyum 147526-32-7 COA

Pitavastatin Calcium 147526-32-7

MORE_DETAIL Pitavastatin Kalsiyum 147526-32-7

Pitavastatin Kalsiyum 147526-32-7 temel bilgiler

Name

Pitavastatincalcium

CAS:

147526-32-7

Molecular Formula

C50H46CaF2N2O8

Molecular Weight

880.98

Quality Standard

In-house Standard, Assay: >99.0%

Package Size

For small quantity: Double plastic bag inside, Aluminum foil bag outside

For commercial quantity: 25kg fiber drum & Aluminum tin

Brief Introduction

Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication 
class of statins, marketed in the United States under the trade name Livalo. Like other statins, it
is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.

It has been available in Japan since 2003, and is being marketed in South Korea and in India.
[2] It is expected that pitavastatin will be approved outside Southeast Asia as well.
[3] In the US, it received FDA approval in 2009. Kowa Pharmaceuticals is the owner of the American patent to pitavastatin.


Pitavastatin Kalsiyum 147526-32-7 kullanımı

  • Pitavastatin kalsiyum hiperkolesterolemi (yüksek kolesterol) ve kardiyovasküler hastalıkların önlenmesi için endikedir.

Pitavastatin Kalsiyum 147526-32-7 COA

Pitavastatin Calcium 147526-32-7
İlgili Makaleler
Mesaj bırakın Bize E-posta

24 saat içinde sizinle iletişim kuracağız.

  • TEL:+ 86-0592-5854962
  • FAX:+ 86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Kat 16, Huicheng İş Merkezi, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, Çin
//